Cai, H., Li, X., Li, J., Ao, L., Yan, H., Tong, M., . . . Guo, Z. (2015). Tamoxifen therapy benefit predictive signature coupled with prognostic signature of post-operative recurrent risk for early stage ER+ breast cancer. Oncotarget.

Cai, Hao, Xiangyu Li, Jing Li, Lu Ao, Haidan Yan, Mengsha Tong, Qingzhou Guan, Mengyao Li, e Zheng Guo. "Tamoxifen Therapy Benefit Predictive Signature Coupled With Prognostic Signature of Post-operative Recurrent Risk for Early Stage ER+ Breast Cancer." Oncotarget 2015.

Cai, Hao, et al. "Tamoxifen Therapy Benefit Predictive Signature Coupled With Prognostic Signature of Post-operative Recurrent Risk for Early Stage ER+ Breast Cancer." Oncotarget 2015.